A lyukas gumi miatt keletkezett terhesség megszakításában miért nem egyenjogú az erről hozható döntés?
Most ha a nő meg akarja tartani akkor lesz baba, de a férfinek nincs beleszólása.
Nem úgy kéne legyen, hogy ha akár egyik fél nemet mond(mindegy melyik), akkor abortusz, és csak akkor lesz gyerek ha mindkét fél igent mond.
Ha már annyira harcol mindenki az egyenjogúságért, ez egy elég korrekt ajánlat
#63, Kategórikusan visszautasítom és kikérem magamnak azt a manapság sajnos eléggé elterjedt női agyrémet, ami egy méhtartalmat egy megszületett ember elé helyez bármiféle módon.
Tehát a te tökeidhez tartozó vezetékek értékesebbek pusztán azért, mert te már megszülettél?
A nőnek a méhe nem annyira értékes, abba bele lehet kapirgálni, pedig ő is egy, már megszületett ember?
És ez akkor is így van ha a "méhtartalom" nélküled nem jött volna létre?
A te vezetékeid fontosak, a nő méhe nem fontos? A nőnek csak a punci-része fontos?
Tisztázzunk valamit: bár minden téren ez ellen a debil ellen vagyok, aki szerint neki joga van nem védekezni, aztán a nőt rákényszeríteni egy abortuszra, és az ő világában ez teljesen helyes megoldás, az abortusz valóban altatásban történik. Itthon legalábbis mindenképp.
Csináltam már életemben párat, szóval tudom. Nem kábítanak, hanem rövid vénás, de teljes anesztézia van, amihez Propofolt és Fentanylt használnak. Nem éreznek semmit és nem is emlékeznek semmire.
(Nekem gyomor- és vastagbéltükrözést csináltak Propofollal, valóban semmire nem emlékszem. Elaludtam, aztán felkeltem, ennyi.)
Egy rövid időszak volt a Covid alatt, mikor ehelyett lokális érzéstelenítésben csináltuk (szuri a méhszájba) némi szedációval, de azt is úgy csinálták az anesztesek, hogy semmire nem emlékeztek belőle.
Szóval az abortuszban egyáltalán nem maga a műtéti fájdalom az, ami problémás. Hanem az, hogy akármennyire is odafigyel az ember, benne van a pakliban, hogy residuum marad, amitől fertőzést kap, ne adj isten, kilyukasztja a nő méhét, de a későbbiekben előfordulhat Asherman-szindróma is. Hiába nem gyakori az inter utáni meddőség vagy a súlyosabb szövődmény, azért ritkán előfordul. És a legtöbb nő annak ellenére, hogy valami miatt asztalra feküdt, azért a későbbiekben még akar gyereket.
#74, hidd el, a "szárnyas patkányok" (aka galambok) sokkal vitaképesebbek mint a vér-feministák, akik mindenáron jobban akarnak járni mint a férfiak, és önmagukat szeretik a legjobban...
#76, és a férfi műtétje esetén mi van benne a pakliban? (te legalább láthatóan tudod miről beszélsz, szemben itt néhány beíróval, akinek csak a hitei vannak meg)
"Hematoma — Bleeding and/or hematoma formation is the most common complication associated with vasectomy. In rare cases, bleeding may be severe enough to require reoperation for scrotal exploration, hematoma evacuation, and control of bleeding. The most common site of bleeding is the pampiniform plexus of veins.
Hematoma rates are lower for no-scalpel procedures, where tissue dissection is minimized [31,50]. Hematoma formation occurs in 0.1 to 2.1 percent of men undergoing no-scalpel procedures, compared with 0.3 to 10.7 percent for incisional technique [51].
Infection — Randomized trials comparing no-scalpel and conventional incisional techniques also demonstrate lower wound infection rates for no-scalpel procedures [31,50]. Infection rates reported for the no-scalpel and incisional techniques are 0.2 to 0.9 and 1.3 to 4 percent, respectively [51].
Sperm granuloma — Sperm are highly antigenic and stimulate a significant inflammatory reaction. A sperm granuloma may form when sperm leaks from the testicular side of an open-ended vas following vasectomy. Less commonly, they may form with extravasation from a cauterized or fulgurated vas.
These granulomas are rarely symptomatic and may be protective to the testis and epididymis. The granuloma is rich in epithelial-lined channels that may vent leaking sperm away from the epididymis and protect against increased intraepididymal pressure.
Most granulomas are asymptomatic and over time will ultimately resorb. Granulomas, however, have been implicated in increased rates of post-vasectomy pain and in vas recanalization related to the inflammatory response induced by the antigenic reaction to sperm [52]. Patients with an acute symptomatic granuloma typically present two to three weeks after vasectomy, after they have resumed sexual activities. A tender mass can be palpated near the cut testicular end of the vas. Most patients respond to supportive care including nonsteroidal anti-inflammatory drugs (NSAIDs); surgery is rarely needed.
Epididymitis — Congestive epididymitis can occur at any time after vasectomy. The open-ended technique may in theory reduce that risk. (See 'Managing the vasal ends' above.)
Post-vasectomy pain syndrome — Post-vasectomy pain syndrome is distinct from postprocedure pain; however, there is some controversy regarding its definition and therefore prevalence [53]. Historically, rates for post-vasectomy pain syndrome have been reported as very low (<1 percent). However, surveys have found that the incidence of "troublesome" post-vasectomy pain is reported by approximately 15 percent of men, with pain severe enough to impact quality of life in 2 percent; survey respondents, however, may not have been representative of all post-vasectomy men [54-57].
The cause of most post-vasectomy pain syndromes is chronic congestive epididymitis [54]. Testicular fluid and sperm production remain constant following vasectomy. The majority of this fluid accumulates in the epididymis, which then swells. While asymptomatic in most men, some will develop a chronic dull ache in the testes, which is made worse by ejaculation. Other causes or contributors to pain syndromes include the formation of sperm granuloma or nerve entrapment at the vasectomy site.
First-line therapy for post-vasectomy pain is the administration of nonsteroidal anti-inflammatory medications and warm baths. If unsuccessful, local nerve blocks or steroid injections may be performed by a pain specialist. If the post-vasectomy patient's discomfort is localized to a tender, palpable granuloma, this may be excised, followed by fulguration of the leaking end of the vas [58].
Refractory cases may require surgery, including either vasectomy reversal (vasovasostomy) or complete epididymectomy. Vasovasostomy successfully relieves pain in up to 70 to 82 percent of well-selected patients [59,60]. These patients, however, will almost always require the use of another form of contraception as a result. (See 'Vasectomy reversal' below.)
Complete epididymal resection is reserved for the most severe cases. Injury to the testicular blood supply, a known complication of this procedure, causes testicular atrophy. Thirty to 90 percent of patients undergoing epididymectomy for post-vasectomy orchialgia will have residual scrotal pain [61].
Vasectomy failure — Vasectomy failure can be due to technical errors, recanalization, or unprotected intercourse before azoospermia is documented.
The varying techniques employed in vasectomy to fulgurate, ligate, and manage the vasal ends are associated with different failure rates. Representative failure rates are listed below [62]:
●Cautery (both ends) and fascial interruption: 1.2 percent or less
●Cautery (prostatic end only) and fascial interruption (clip): 0.02 to 2.4 percent
●Cautery of both ends and excision of a segment: 4.8 percent or less
●Ligation and fascial interruption: 16.7 percent or less
●Ligation and excision of segment: 1.5 to 29 percent
●Intraluminal needle cautery (vas not transected, no segment removed; rarely performed in North America): Less than 1 percent [29,63]
Recanalization is rare, occurring in approximately 0.2 percent of patients [52]. It is defined as the presence of any spermatozoa after one or more previously azoospermic samples were properly collected and documented [64]. It can occur at any time following vasectomy.
Terhességmegszakítás:
"First-trimester aspiration abortion is a safe procedure, with an overall complication rate of 9.05 per 1000 [55]. Major complications (suspected perforation, ectopic pregnancy, hemorrhage, sepsis) are very rare (0.71 per 1000). The overall mortality rate associated with legal abortion in the United States is 0.7 per 100,000, with markedly reduced rates at lower gestations (0.1 per 100,000 at <8 weeks, 0.2 per 100,000 at 9 to 10 weeks, and 0.4 per 100,000 at 11 to 12 weeks) [56]. In the first trimester, infection is the most common cause of abortion-related mortality (31 percent), with anesthesia complications accounting for 22 percent and hemorrhage accounting for 14 percent of deaths [56]. (See "Overview of pregnancy termination", section on 'Complications'.)
Aspiration abortion procedures performed in an outpatient setting have low rates of morbidity and mortality, comparable to procedures performed within a hospital setting [57,58]. Potential immediate complications include hemorrhage, cervical laceration, and uterine perforation. These complications occurred in only 0.06 percent of 170,000 consecutive cases reported in one series from Planned Parenthood [55]. In this series, 0.07 percent of patients required hospitalization because of incomplete abortion, sepsis, uterine perforation, hemorrhage, inability to complete the procedure, or combined (intrauterine and tubal) pregnancy. Minor complications, such as mild infection, incomplete abortion requiring reaspiration in an ambulatory setting, cervical stenosis or laceration, or convulsive seizure due to administration of local anesthetic, occurred in 0.84 percent.
A systematic review of complications from first-trimester aspiration abortion included 57 studies and calculated the incidence of hemorrhage not requiring transfusion (<5 percent), major complications including hemorrhage requiring transfusion and uterine perforation requiring repair (≤0.1 percent), hospitalizations (≤0.5 percent), and repeat aspirations (<3 percent). No abortion-related deaths were reported [58].
Infection — Postabortal endometritis occurs in 5 to 20 percent of patients who undergo first-trimester aspiration abortion and do not receive prophylactic antibiotics [12]. With the use of antibiotic prophylaxis, the infection rate is reduced significantly; in the large case series of 170,000 patients, 784 (0.46 percent) experienced a mild infection and only 36 (0.021 percent) were classified with a diagnosis of sepsis [55]. In a 2015 systematic review, of the six office-based studies in which all patients received antibiotic prophylaxis, <2 percent of patients in five of these studies required outpatient treatment for presumed or diagnosed infection [58].
Postabortal pelvic infections are generally diagnosed clinically. Patients usually present with one or more of the following: fever; lower abdominal or pelvic pain; adnexal, uterine, or cervical motion tenderness on examination; friable cervix; excessive or abnormal bleeding; or abnormal vaginal discharge. Patients who are hemodynamically stable and are not toxic-appearing may be presumptively treated as an outpatient with a trial of broad-spectrum antibiotic therapy, including coverage of anaerobes, in accordance with Centers for Disease Control and Prevention guidelines for pelvic inflammatory disease. Any retained products of conception (POC) or blood clot found on ultrasound in the setting of suspected infection should be evacuated. (See "Pelvic inflammatory disease: Treatment in adults and adolescents" and 'Retained products of conception' below.)
Generalized abdominal tenderness, guarding, tachycardia, high fever, and prostration suggest peritonitis or potential sepsis. These patients require aggressive therapy with broad spectrum intravenous antibiotics, uterine re-evacuation, assessment for uterine perforation, and inpatient monitoring and support, possibly in an intensive care unit.
Hemorrhage — Postabortal hemorrhage is rare with first-trimester aspiration abortion and may result from uterine atony, cervical or vaginal lacerations, uterine perforation, or retained tissue. Our approach is similar to The Society of Family Planning guidelines which are discussed in detail separately [59]. (See "Overview of pregnancy termination", section on 'Hemorrhage'.)
Abnormal placentation is rare in the late first and early second trimester, but may result in significant bleeding with aspiration abortion. Risk factors include prior cesarean delivery or a history of other uterine surgeries (particularly if there was an incision from the endometrial cavity into the myometrium). If abnormal placentation is suspected prior to the procedure, additional precautions should be taken such as using intraoperative ultrasound, avoiding direct suction or sharp curettage over the uterine scar or area of suspected abnormal implantation, having an electric vacuum aspirator immediately available, and/or advance notification of back-up providers (eg, gynecologic surgeon or interventional radiologist). Depending on availability and access, providers may consider performing the procedure in the operating room and with blood products available. (See "Cesarean scar pregnancy, abdominal pregnancy, and heterotopic pregnancy", section on 'Cesarean scar pregnancy'.)
Cervical laceration — Cervical or vaginal trauma from first-trimester uterine aspiration is rare (≤0.1 percent) [58], but risk can be reduced by appropriate cervical preparation in patients in whom difficult mechanical dilation is anticipated. Most cervical or vaginal trauma during first-trimester uterine aspiration can be controlled with direct pressure for one to two minutes. For cervical lacerations, application of silver nitrate or ferric subsulfate (Monsel solution) may be useful. For cervical lacerations that have persistent bleeding, surgical repair with absorbable sutures is recommended.
Uterine perforation — For both first- and second-trimester procedures, the reported rate of uterine perforation is less than 0.6 percent [60-62]. Among first-trimester procedures alone, one study of 170,000 patients had only 16 cases (<0.01 percent) of uterine perforation requiring additional measures [55]. In a systematic review of first-trimester abortions, the majority of office- and hospital-based studies reported no cases of uterine perforation requiring additional surgery or hospitalization.
When uterine perforation is suspected, the aspiration procedure should be stopped to evaluate the extent of the perforation using ultrasound guidance. If there is no evidence of vascular or visceral injury and the procedure is not complete, the procedure can continue under ultrasound guidance if the remaining pregnancy tissue can be safely reached. The procedure may also be postponed for one to two weeks to allow closure of the perforation, and subsequent aspiration should be performed under ultrasound guidance. Further surgical intervention may be indicated if hemorrhage is persistent or there is evidence of visceral injury.
Expectant management of uterine perforation typically includes monitoring of vital signs and symptoms (uterine tenderness, vaginal bleeding) for one to two hours and postprocedure ultrasound to evaluate for free fluid in the pelvis. Anaerobic coverage with metronidazole 500 mg by mouth twice daily for one week is common, but no studies have addressed this practice. Further details on uterine perforation are discussed separately. (See "Uterine perforation during gynecologic procedures".)
Hematometra — Immediate postoperative pain without overt bleeding from the vagina may indicate development of hematometra. Hematometra usually presents with complaints of dull, aching lower abdominal pain, sometimes accompanied by tachycardia, diaphoresis, or nausea. The onset is usually within the first hour after completion of the procedure.
Pelvic examination reveals a large midline globular uterus that is tense and tender, or an enlarged uterine cavity filled with echogenic material on ultrasound. Treatment requires immediate uterine evacuation, permitting the uterus to contract to a normal postprocedure size. Administration of intramuscular methylergonovine maleate (0.2 mg) may be given to ensure continued contraction of the uterus [63].
Retained products of conception — Retained POC (ie, placental tissue, fetal fragments, fetal membranes) is an uncommon complication of abortion by uterine aspiration. In one series with follow-up information on 80 percent of patients who underwent pregnancy termination, retained POC were present in 4 of 672 first-trimester procedures [64].
It may be difficult to distinguish retained POC from hematometra or infectious endometritis based on clinical evaluation alone. These postabortion entities may all present with similar symptoms and examination findings: lower abdominal or pelvic pain and an enlarged or tender uterus. Hematometra is more likely when the presentation of pain is immediately postabortion (within one hour) and without heavy vaginal bleeding. Retained POC is more likely when the presentation is delayed and accompanied by heavy or persistent vaginal bleeding days or weeks after the procedure. An infectious etiology is more likely to be accompanied by fever, or when pain is not associated with sonographic evidence of retained tissue in the uterine cavity [65].
Any physical or sonographic evidence of retained POC should prompt consideration of suction curettage to complete evacuation of the uterus, especially in the acutely symptomatic patient. Misoprostol is an alternative treatment for retained POC in doses used for incomplete abortions or miscarriages: 600 mcg orally or 400 mcg sublingually [66]. One study published a misoprostol success rate of 93 percent to treat retained POC in 88 patients and a corresponding decrease in the use of repeat dilation and curettage [67].
Ongoing pregnancy — Ongoing pregnancy is more likely to be a complication of early rather than late abortion. All patients will continue to have an elevated level of hCG for a short period following pregnancy termination. Return of the serum hCG concentration to undetectable following pregnancy termination varies widely from 7 to 60 days [50]. The period of time depends primarily upon the hCG concentration at the time of termination. The hCG concentration peaks at 8 to 11 weeks of gestation at approximately 90,000 milli-international units per mL. This is in contrast with term pregnancy, for which the hCG concentration is lower. The decline in serum hCG is rapid for the first several days (half-life 9 to 31 hours) and then proceeds more slowly (half-life 55 to 64 hours) [51,68,69]. (See "Human chorionic gonadotropin: Biochemistry and measurement in pregnancy and disease".)
An ongoing intrauterine pregnancy may occur after an attempted pregnancy termination if the clinician fails to recognize a sufficient amount of gestational tissue upon examination postprocedure to verify successful completion (see 'Tissue evaluation' above). Alternatively, ongoing pregnancy may rarely result from a multiple gestation in which only one of the sacs was aborted. In one series of 12,138 consecutive abortions with careful examination of the pathologic specimen, three continuing pregnancies were later diagnosed and attributed to clinician error [45]. Two were at six weeks and one was at eight weeks of gestation. A second series reported an ongoing pregnancy rate of 1.3 per 1000 procedures for pregnancies less than six weeks of gestation [47].
The type and risk of possible damage to the ongoing pregnancy from an attempted abortion cannot be quantified. Direct or indirect injury to the developing embryo could occur. One preliminary report suggested there may be an increased risk of Moebius sequence with autism in children exposed to misoprostol in the first trimester [70]. Moebius sequence is a clinical condition characterized by ophthalmic-facial palsy and muscle or bone malformations in the limbs. It represents a cascade of events resulting from embryo trauma from varied etiologies (eg, genetic factors, environmental injuries, prolonged membrane ruptures and chorionic villus sampling). (See "Misoprostol as a single agent for medical termination of pregnancy", section on 'Teratogenicity'.)"
De megjegyzem, nem sok értelme van a kettőt egymáshoz hasonlítani.
Ugyanis a férfi sterilizációnak a megfelelője az a női sterilizáció, ami egyébként nagyobb rizikót jelent, mint a férfi sterilizáció.
Amikor a nőnek abortuszra "kell" menni, az a férfinek nulla egészségügyi kockázatot jelent.
A példát csak azért hozta fel valaki, mert ugye egy férfit sem lehet akarata ellenére egy -egyébként nagyon kis rizikójú- beavatkozásra kényszertíeni, akkor egy nőt miért lehetne egy szintén kicsi, de azért mégis rizikókat magában hordozó beavatkozásra kényszeríteni?
A gyerek megcsinálásához kettő ember szükséges, elég alja dolog a terhesség esetén az anyára tolni az összes felelősséget.
Kapcsolódó kérdések:
Minden jog fenntartva © 2025, www.gyakorikerdesek.hu
GYIK | Szabályzat | Jogi nyilatkozat | Adatvédelem | Cookie beállítások | WebMinute Kft. | Facebook | Kapcsolat: info(kukac)gyakorikerdesek.hu
Ha kifogással szeretne élni valamely tartalommal kapcsolatban, kérjük jelezze e-mailes elérhetőségünkön!